Method to evaluate intravenous maintenance tocolysis for preterm labor.

Area of Science:

• Obstetrics and Gynecology
• Perinatology
• Clinical Pharmacology

Background:

• Continuous intravenous maintenance tocolysis is a standard treatment for preterm labor (PTL) in Japan, despite limited evidence-based support.
• The primary goal of this treatment is to prolong gestational duration.

Purpose of the Study:

• To evaluate the effectiveness of maintenance tocolysis for PTL.
• To propose a method for assessing maintenance tocolysis based on delivery timing.
• To identify potential risks of overtreatment.

Main Methods:

• 307 PTL patients were categorized into three groups based on delivery weeks: severe PTL (<34 weeks), mild PTL (34-37 weeks), and suspected overtreatment (≥38 weeks).
• Clinical characteristics, including inflammatory markers and neonatal intensive care unit (NICU) stay, were compared across groups.
• Statistical analysis, including analysis of variance, was employed to determine significant differences.

Main Results:

• Patient distribution was 33.9% in the severe PTL group, 43.6% in the mild PTL group, and 22.5% in the suspected overtreatment group.
• Significant differences were observed in gestational weeks at admission, maternal inflammatory markers (white blood cell count, C-reactive protein), PTL index, fetal fibronectin levels, and amniotic fluid interleukin-8 levels between the groups.
• Amniotic fluid interleukin-8 levels were notably higher in the mild PTL group compared to the suspected overtreatment group.

Conclusions:

• Patient classification by delivery prognosis provides a metric for PTL severity and overtreatment risk.
• Nationwide analysis of these ratios may necessitate a re-evaluation of current intravenous maintenance tocolysis practices and the definition of PTL.